State of New Jersey Common Pension Fund D’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$592K Sell
27,093
-875
-3% -$18.2K ﹤0.01% 1612
2026
Q1
$653K Buy
+27,968
New +$608K ﹤0.01% 1432
2025
Q1
Sell
-133,111
Closed -$1.76M 1561
2024
Q4
$1.76M Buy
133,111
+38,339
+40% +$656K 0.01% 1472
2024
Q3
$1.82M Buy
94,772
+459
+0.5% +$9.48K 0.01% 1444
2024
Q2
$1.94M Sell
94,313
-20,071
-18% -$420K 0.01% 1096
2024
Q1
$2.72M Sell
114,384
-45,419
-28% -$1.01M 0.01% 1395
2023
Q4
$3.45M Buy
159,803
+26,769
+20% +$411K 0.01% 844
2023
Q3
$1.93M Buy
133,034
+13,063
+11% +$247K 0.01% 1541
2023
Q2
$2.51M Buy
119,971
+36,532
+44% +$761K 0.01% 1311
2023
Q1
$1.76M Buy
+83,439
New +$2.08M 0.01% 1585

Other funds holding SNDX

State of New Jersey Common Pension Fund D's SNDX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Syndax Pharmaceuticals (SNDX) stake by 3.1% in Q2 2026, selling an estimated $18.2K and leaving 27,093 shares worth $592K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

State of New Jersey Common Pension Fund D first reported a position in SNDX in Q1 2023 and has held it in 10 quarters since. The position peaked at $3.45M in Q4 2023. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 27,093 shares of Syndax Pharmaceuticals worth $592K as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 875 Syndax Pharmaceuticals shares in Q2 2026, an estimated $18.2K.
  • Syndax Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1612 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Syndax Pharmaceuticals in Q1 2023 and has held it in 10 quarters since.
  • State of New Jersey Common Pension Fund D's Syndax Pharmaceuticals position peaked at $3.45M in Q4 2023.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.